FDA’s Office of International Programs (OIP) works with governments, industry and academia in foreign countries, as well as with multilateral organizations, to help assure that food and medical products exported to the United States meet U.S. standards. Today, with 300,000 foreign facilities from more than 150 countries exporting FDA-regulated products to the United States, FDA works beyond U.S. borders to ensure that products coming into the United States are safe and effective.
Through OIP’s foreign offices, and in close cooperation with FDA Centers and the Office of Regulatory Affairs (ORA), OIP assists FDA decision making by:
- Obtaining foreign scientific and regulatory information,
- conducting inspections and investigations in foreign countries, and
- facilitating collaboration with foreign regulators in areas of common interest.
OIP helps assure the safety of imported products in other ways, for example through:
- Informing foreign industry about U.S. requirements,
- strengthening the capabilities of foreign regulatory authorities,
- participating in U.S. trade negotiations to ensure the continuation of high U.S. safety and efficacy standards, and
- providing FDA’s Centers and Offices with “landscaping” information about the international context in which FDA operates.